Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Elia Bari is active.

Publication


Featured researches published by Elia Bari.


Materials | 2017

In vitro effectiveness of microspheres based on silk sericin and Chlorella vulgaris or Arthrospira platensis for wound healing applications

Elia Bari; Carla Renata Arciola; Barbara Vigani; Barbara Crivelli; Paola Moro; Giorgio Marrubini; Milena Sorrenti; Laura Catenacci; Giovanna Bruni; Theodora Chlapanidas; Enrico Lucarelli; Sara Perteghella; Maria Luisa Torre

Some natural compounds have recently been widely employed in wound healing applications due to their biological properties. One such compound is sericin, which is produced by Bombix mori, while active polyphenols, polysaccharides and proteins are synthetized by Chlorella vulgaris and Arthrospira platensis microalgae. Our hypothesis was that sericin, as an optimal bioactive polymeric carrier for microencapsulation process, could also improve the regenerative effect of the microalgae. A solvent-free extraction method and spray drying technique were combined to obtain five formulations, based on algal extracts (C. vulgaris and A. platensis, Chl and Art, respectively) or silk sericin (Ser) or their mixtures (Chl-Ser and Art-Ser). The spray drying was a suitable method to produce microspheres with similar dimensions, characterized by collapsed morphology with a rough surface. Art and Art-Ser showed higher antioxidant properties than other formulations. All microspheres resulted in cytocompatibility on fibroblasts until 1.25 mg/mL and promoted cell migration and the complete wound closure; this positive effect was further highlighted after treatment with Art and Art-Ser. To our surprize the combination of sericin to Art did not improve the microalgae extract efficacy, at least in our experimental conditions.


International Journal of Biological Macromolecules | 2018

In vitro efficacy of silk sericin microparticles and platelet lysate for intervertebral disk regeneration

Elia Bari; Sara Perteghella; Giorgio Marrubini; Milena Sorrenti; Laura Catenacci; Giuseppe Tripodo; Maddalena Mastrogiacomo; Delia Mandracchia; Adriana Trapani; Silvio Faragò; Paolo Gaetani; Maria Luisa Torre

Intervertebral disk degeneration is an oxidative and inflammatory pathological condition that induces viability and functionality reduction of Nucleus Pulposus cells (NPs). Cellular therapies were previously proposed to repair and substitute the herniated disk but low proliferative index and pathological conditions of NPs dramatically reduced the efficacy of this approach. To overcome these problems we proposed, for the first time, a therapeutic system based on the association of silk sericin microparticles and platelet-derived products. Silk sericin (SS) is a bioactive protein with marked antioxidant properties, while platelet lysate (PL) and platelet poor plasma (PPP) represent a source of growth factors able to support cell viability and to promote tissue regeneration. We demonstrated that the mixture PLu202f+u202fPPP promoted NPs proliferation with a significant reduction of cellular doubling time. SS microparticles, alone or in combination with PPP, presented the higher ROS-scavenging activity while, SS microparticles and PL resulted as the best association able to protect NPs against oxidative stress induce by hydroxide peroxide. Based on these results, the authors are confident that, with the ever increasing need of efficacious tools for regenerative medicine purposes, SS microparticles and PLu202f+u202fPPP association could represent an effective approach for the development of low impact and non-invasive therapies.


Polymers | 2018

Human Engineered Cartilage and Decellularized Matrix as an Alternative to Animal Osteoarthritis Model

Marta Galuzzi; Sara Perteghella; Barbara Antonioli; Marta Cecilia Tosca; Elia Bari; Giuseppe Tripodo; Milena Sorrenti; Laura Catenacci; Luca Mastracci; Federica Grillo; Mario Marazzi; Maria Luisa Torre

(1) Objective: to obtain a reproducible, robust, well-defined, and cost-affordable in vitro model of human cartilage degeneration, suitable for drug screening; (2) Methods: we proposed 3D models of engineered cartilage, considering two human chondrocyte sources (articular/nasal) and five culture methods (pellet, alginate beads, silk/alginate microcarriers, and decellularized cartilage). Engineered cartilages were treated with pro-inflammatory cytokine IL-1β to promote cartilage degradation; (3) Results: articular chondrocytes have been rejected since they exhibit low cellular doubling with respect to nasal cells, with longer culture time for cell expansion; furthermore, pellet and alginate bead cultures lead to insufficient cartilage matrix production. Decellularized cartilage resulted as good support for degeneration model, but long culture time and high cell amount are required to obtain the adequate scaffold colonization. Here, we proposed, for the first time, the combined use of decellularized cartilage, as aggrecanase substrate, with pellet, alginate beads, or silk/alginate microcarriers, as polymeric scaffolds for chondrocyte cultures. This approach enables the development of suitable models of cartilaginous pathology. The results obtained after cryopreservation also demonstrated that beads and microcarriers are able to preserve chondrocyte functionality and metabolic activity; (4) Conclusions: alginate and silk/alginate-based scaffolds can be easily produced and cryopreserved to obtain a cost-affordable and ready-to-use polymer-based product for the subsequent screening of anti-inflammatory drugs for cartilage diseases.


International Journal of Biological Macromolecules | 2018

Association of silk sericin and platelet lysate: Premises for the formulation of wound healing active medications

Elia Bari; Sara Perteghella; Silvio Faragò; Maria Luisa Torre

Silk sericin (SS), a globular and water-soluble protein, showed to in vitro sustain the proliferation of different mammalian cell lines, and to in vitro protect them from the oxidative stress because of its free-radical-scavenging activity. Also, platelet-derived products, such as platelet gel, platelet rich plasma or platelet lysate (PL) are used in cell cultures as a serum substitute due to their great content of growth factors. In the clinical practice, both SS and PL were employed for various reparative treatments and showed to sustain the wound repair process regulating fibroblast recruitment, migration, proliferation and differentiation. For these reasons, the combination of PL and SS could lead to effective and innovative products, either for the ex vivo cell expansion, or for the production of active wound healing advanced medications.


Soft Matter | 2018

Silk nanoparticles: from inert supports to bioactive natural carriers for drug delivery

Barbara Crivelli; Sara Perteghella; Elia Bari; Milena Sorrenti; Giuseppe Tripodo; Theodora Chlapanidas; Maria Luisa Torre


Archive | 2018

Lyosecretome for use in the treatment of autoimmune diseases

Elia Bari; Angelo Corsico; Ilaria Ferrarotti; Gaetani Paolo; Sara Perteghella; Sorlini Marzio; Maria Luisa Torre


Archive | 2018

Lyosecretome for use in the treatment of alpha-1-antitrypsin deficiency associated diseases

Elia Bari; Angelo Corsico; Ilaria Ferrarotti; Gaetani Paolo; Sara Perteghella; Sorlini Marzio; Maria Luisa Torre


Archive | 2018

Lyosecretome for use in the treatment of degenerative osteoarticular diseases and/or degenerative intervertebral disc disease.

Elia Bari; Angelo Corsico; Ilaria Ferrarotti; Gaetani Paolo; Sara Perteghella; Sorlini Marzio; Maria Luisa Torre


Archive | 2018

PROCESS FOR ISOLATING AND LYOPHILIZING EXTRACELLULAR VESICLES

Sara Perteghella; Elia Bari; Theodora Chlapanidas; Marzio Sorlini; Laura de Girolamo; Carlotta Perucca Orfei; Marco Viganò; Maria Luisa Torre


11th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology | 2018

Mesenchymal stem/stromal cell Lyosecretome for next generation cell-free regenerative nanomedicine

Elia Bari; Sara Perteghella; Sorlini Marzio; Milena Sorrenti; Laura Catenacci; Marrubini Giorgio; Giuseppe Tripodo; Maria Luisa Torre

Collaboration


Dive into the Elia Bari's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge